Antiviral resistance and direct- acting antiviral agents for HCV

Grants

Funding Acknowledgements

The authors are grateful to Alexander Thompson of St Vincent's Hospital Melbourne for providing the image used in Figure 3 and Grant Booker of The University of Adelaide for providing the image used in Figure 4. This work was funded, in part, by an NHMRC program grant (510488) to MRB.MRB has received research grants from Merck Sharpe and Dohme Pty Ltd. SL is an advisor for Gilead, Bristol-Myers Squibb and Merck Sharpe and Dohme Pty Ltd, and is a Section Editor for Antiviral Therapy. ALA declares no competing interests.